Published in Am J Transplant on August 10, 2011
Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol (2013) 2.10
Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol (2013) 1.64
The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol (2012) 1.29
Progress and Trends in Complement Therapeutics. Adv Exp Med Biol (2013) 1.20
Complement in disease: a defence system turning offensive. Nat Rev Nephrol (2016) 0.97
Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment. World J Transplant (2015) 0.90
Applying complement therapeutics to rare diseases. Clin Immunol (2015) 0.87
Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. Methods Mol Biol (2013) 0.84
New milestones ahead in complement-targeted therapy. Semin Immunol (2016) 0.81
From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage. Immunobiology (2016) 0.80
Strategies to overcome the ABO barrier in kidney transplantation. Nat Rev Nephrol (2015) 0.78
Accommodation: how you see it, how you don't. Am J Transplant (2011) 0.76
Current progress in ABO-incompatible kidney transplantation. Kidney Res Clin Pract (2015) 0.76
The Complement System and Antibody-Mediated Transplant Rejection. J Immunol (2015) 0.76
Acute Antibody-Mediated Rejection in Renal Transplantation: Current Clinical Management. Curr Transplant Rep (2014) 0.76
Rational clinical trial design for antibody mediated renal allograft injury. Front Biosci (Landmark Ed) (2015) 0.75
Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications. J Immunol Res (2017) 0.75
Computational Biology: Modeling Chronic Renal Allograft Injury. Front Immunol (2015) 0.75
All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature (2001) 11.72
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem (2010) 8.79
Radical SAM, a novel protein superfamily linking unresolved steps in familiar biosynthetic pathways with radical mechanisms: functional characterization using new analysis and information visualization methods. Nucleic Acids Res (2001) 6.49
TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun (1999) 6.33
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes (2000) 6.27
An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol (1994) 5.87
Gene expression profiles of laser-captured adjacent neuronal subtypes. Nat Med (1999) 5.12
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (1996) 5.06
Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science (1996) 4.59
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57
ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell (2001) 4.38
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res (1999) 4.16
Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell (1998) 4.03
PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization. Cell (1998) 3.79
PML is essential for multiple apoptotic pathways. Nat Genet (1998) 3.75
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67
Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene (2009) 3.64
Plant paralog to viral movement protein that potentiates transport of mRNA into the phloem. Science (1999) 3.51
Enhancement of blue-light sensitivity of Arabidopsis seedlings by a blue light receptor cryptochrome 2. Proc Natl Acad Sci U S A (1998) 3.34
Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol Cell (1998) 3.09
Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A (1997) 3.07
The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res (1995) 3.04
Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04
Group II intron mobility occurs by target DNA-primed reverse transcription. Cell (1995) 2.86
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
Antagonistic actions of Arabidopsis cryptochromes and phytochrome B in the regulation of floral induction. Development (1999) 2.76
Coordination of a transcriptional switch by HMGI(Y) acetylation. Science (2001) 2.69
BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem (2000) 2.68
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol (2000) 2.58
Site-directed mutagenesis using overlap extension PCR. Methods Mol Biol (1996) 2.49
New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet (2001) 2.44
A group II intron RNA is a catalytic component of a DNA endonuclease involved in intron mobility. Cell (1995) 2.37
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res (2001) 2.35
Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development (1992) 2.34
Lithium-induced increase in human brain grey matter. Lancet (2000) 2.31
alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc Natl Acad Sci U S A (1998) 2.28
PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic. EMBO J (2001) 2.26
The function of PML in p53-dependent apoptosis. Nat Cell Biol (2000) 2.24
Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol (1997) 2.10
Raman scattering from high-frequency phonons in supported n-graphene layer films. Nano Lett (2006) 2.08
Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem (2001) 2.08
Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria. Nat Biotechnol (2001) 2.06
MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol (1997) 2.02
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest (2001) 2.00
Conversion of dorsal from an activator to a repressor by the global corepressor Groucho. Genes Dev (1997) 1.99
Thermal conductivity spectroscopy technique to measure phonon mean free paths. Phys Rev Lett (2011) 1.94
Local and propagated vascular responses evoked by focal synaptic activity in cerebellar cortex. J Neurophysiol (1997) 1.93
Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet (2001) 1.91
Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. Mol Pharmacol (2001) 1.90
Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun (2001) 1.88
Protein folding is slaved to solvent motions. Proc Natl Acad Sci U S A (2006) 1.88
RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell (1999) 1.85
Effect of NASA light-emitting diode irradiation on wound healing. J Clin Laser Med Surg (2001) 1.85
Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Mol Psychiatry (2010) 1.83
Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc Natl Acad Sci U S A (2000) 1.80
MicroRNA-146a and human disease. Scand J Immunol (2010) 1.80
Lumbar hernia: clinical analysis of 11 cases. Hernia (2004) 1.79
Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol (2006) 1.79
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer (2004) 1.76
Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr (1995) 1.73
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol (1997) 1.73
The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J Biol Chem (2001) 1.73
Control of protein-ligand recognition using a stimuli-responsive polymer. Nature (1995) 1.73
Drosophila RNA polymerase II elongation factor DmS-II has homology to mouse S-II and sequence similarity to yeast PPR2. Nucleic Acids Res (1990) 1.72
Internal structure and early thermal evolution of Mars from Mars Global Surveyor topography and gravity. Science (2000) 1.71
Experimental investigation of heat conduction mechanisms in nanofluids. Clue on clustering. Nano Lett (2009) 1.71
Frequency and effect of negative comments ("badmouthing") on medical students' career choices. Acad Med (1996) 1.71
Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. Mol Cell Biol (1998) 1.71
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology (2000) 1.70
Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. Clin Infect Dis (2001) 1.70
CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci U S A (2001) 1.69
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry (2008) 1.66
Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay. Carcinogenesis (1996) 1.65
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study. Int J Clin Pract (2012) 1.65
Oral health behavior and metabolic syndrome and its components in adults. J Dent Res (2012) 1.64
Phloem sap proteins from Cucurbita maxima and Ricinus communis have the capacity to traffic cell to cell through plasmodesmata. Proc Natl Acad Sci U S A (1997) 1.64
Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene (1996) 1.64
Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry (1995) 1.63
The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J (1999) 1.62
GRAB proteins, novel members of the NAC domain family, isolated by their interaction with a geminivirus protein. Plant Mol Biol (1999) 1.62
Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. J Natl Cancer Inst (1995) 1.60
Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci (2014) 1.59
Use of voltage-sensitive dyes and optical recordings in the central nervous system. Prog Neurobiol (1995) 1.58
Evans syndrome: results of a national survey. J Pediatr Hematol Oncol (1997) 1.56
Multipathway risk assessment on disinfection by-products of drinking water in Hong Kong. Environ Res (2004) 1.56
Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry (2000) 1.55
The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site. Proc Natl Acad Sci U S A (1996) 1.54
Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry (2000) 1.53
Radiation risk to low fluences of alpha particles may be greater than we thought. Proc Natl Acad Sci U S A (2001) 1.53
Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus. Mol Cell (2000) 1.52
Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China. Am J Trop Med Hyg (1994) 1.52
An interesting case of rifampicin-dependent/-enhanced multidrug-resistant tuberculosis. Int J Tuberc Lung Dis (2010) 1.52
Increased phonon scattering by nanograins and point defects in nanostructured silicon with a low concentration of germanium. Phys Rev Lett (2009) 1.50
The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48
Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol (1999) 1.48
Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology (2008) 1.46